%0 Journal Article %J Br J Ophthalmol %D 2023 %T PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair %A Cai, Louis Z %A Lin, Jeffrey %A Starr, Matthew R %A Obeid, Anthony %A Ryan, Edwin H %A Ryan, Claire %A Forbes, Nora J %A Arias, Diego %A Ammar, Michael J %A Patel, Luv G %A Capone, Antonio %A Emerson, Geoffrey Guy %A Joseph, Daniel P %A Eliott, Dean %A Gupta, Omesh P %A Regillo, Carl D %A Hsu, Jason %A Yonekawa, Yoshihiro %A Primary Retinal Detachment Outcomes (PRO) Study Group %K Humans %K Retina %K Retinal Detachment %K Retrospective Studies %K Scleral Buckling %K Vitrectomy %K Vitreoretinopathy, Proliferative %K Vitreous Body %X BACKGROUND/AIMS: To compare risk factors for poor visual outcomes in patients undergoing primary rhegmatogenous retinal detachment (RRD) repair and to develop a scoring system. METHODS: Analysis of the Primary Retinal detachment Outcomes (PRO) study, a multicentre interventional cohort of consecutive primary RRD surgeries performed in 2015. The main outcome measure was a poor visual outcome (Snellen VA ≤20/200). RESULTS: A total of 1178 cases were included. The mean preoperative and postoperative logMARs were 1.1±1.1 (20/250) and 0.5±0.7 (20/63), respectively. Multivariable logistic regression identified preoperative risk factors predictive of poor visual outcomes (≤20/200), including proliferative vitreoretinopathy (PVR) (OR 1.26; 95% CI 1.13 to 1.40), history of antivascular endothelial growth factor (VEGF) injections (1.38; 1.11 to 1.71), >1-week vision loss (1.17; 1.08 to 1.27), ocular comorbidities (1.18; 1.00 to 1.38), poor presenting VA (1.06 per initial logMAR unit; 1.02 to 1.10) and age >70 (1.13; 1.04 to 1.23). The data were split into training (75%) and validation (25%) and a scoring system was developed and validated. The risk for poor visual outcomes was 8% with a total score of 0, 17% with 1, 29% with 2, 47% with 3, and 71% with 4 or higher. CONCLUSIONS: Independent risk factors were compared for poor visual outcomes after RRD surgery, which included PVR, anti-VEGF injections, vision loss >1 week, ocular comorbidities, presenting VA and older age. The PRO score was developed to provide a scoring system that may be useful in clinical practice. %B Br J Ophthalmol %V 107 %P 555-559 %8 2023 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/34815237?dopt=Abstract %R 10.1136/bjophthalmol-2021-320440